Emyria in ‘final stages’ of winding down Emerald Clinics by Steve Jones September 3, 2024September 3, 2024 Emyria is winding down its cannabis clinic business to focus on MDMA-assisted therapy as its chief […]
LGP dealt first strike over pay packets despite three-year salary freeze by Steve Jones September 3, 2024September 3, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
The battle for Australian-grown cannabis: quality vs global price wars by Michael Sassano September 2, 2024September 2, 2024
Impairment charge sees Althea losses sink to $32m despite revenue growth by Steve Jones August 30, 2024September 2, 2024
Profits, margins and prices fall as Vitura is hit by rising competition by Steve Jones August 29, 2024August 29, 2024
Australian firm ECC Pharm expands footprint in Germany with double acquisition by Steve Jones August 29, 2024August 29, 2024
Lyphe Australia exits clinic sector, axes MSL team, but sets new course for product growth by Steve Jones August 29, 2024August 29, 2024
ECS Botanics reports A$2m profit in ‘extremely positive year’ by Steve Jones August 28, 2024August 28, 2024
